Transfection of human mutated K-ras in mouse NIH-3T3 cells is associated with increased cloning efficiency and DNA

S Nigro1, E Geido, E Infusini

  • 1Laboratory of Biophysics and Cytometry, National Institute for Cancer Research (I.S.T.), Genoa, Italy.

Insights

A mutated human K-ras oncogene in mouse cells caused abnormal cell division and increased the rate of sub-clone development. These K-ras-driven sub-clones showed higher cloning efficiency and DNA aneuploidy, indicating genomic instability.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genetics

Background:

  • The K-ras oncogene plays a critical role in cell signaling pathways.
  • Mutations in K-ras are frequently observed in various human cancers.
  • Understanding the downstream effects of mutated K-ras is crucial for cancer research.

Purpose of the Study:

  • To investigate if a mutated human K-ras protein induces mitotic abnormalities and sub-clone development.
  • To determine if these sub-clones exhibit changes in DNA ploidy and proliferation.
  • To assess the impact of activated K-ras on genomic stability.

Main Methods:

  • NIH-3T3 mouse cells were transfected with a mutated human K-ras oncogene (codon 12 G-C).
  • Abnormal mitoses were quantified by observing chromosome behavior during cell division.
  • Sub-clone generation was assessed using limiting-dilution experiments and cloning efficiency.
  • DNA content and cell cycle phase distribution were analyzed by flow cytometry.

Main Results:

  • Transfected cells showed a significantly higher frequency of abnormal mitoses, including lagging chromosomes.
  • K-ras-transfected cells exhibited a markedly increased cloning efficiency (41%) compared to control cells (22%).
  • A higher proportion of DNA aneuploid sub-clones (9%) were generated from K-ras-transfected cells versus control cells (1%).

Conclusions:

  • High expression of the activated human K-ras protein in NIH-3T3 cells is linked to mitotic abnormalities.
  • Mutated K-ras promotes increased cloning efficiency and contributes to DNA aneuploidization.
  • These findings suggest that activated K-ras can drive genomic instability and sub-clone evolution.

Related Concept Videos

In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: